LYTIR

Company · ADRX

ADARx Pharmaceuticals, Inc.

Nasdaq's symbol directory lists ADRX on Nasdaq as “ADARx Pharmaceuticals, Inc. - Common stock”.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($43.4M); 4 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 15, No. 14, No. 13, No. 12, No. 11, No. 10, No. 9, No. 8

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Simeon George bought on 1 day latest Sep 28, 2026 bought $27.2M
  2. ORBIMED ADVISORS LLC bought on 1 day latest Sep 28, 2026 bought $16.1M
Every trade (2)
  1. BUYSimeon George bought Sep 28, 2026 1,600,000 shares 3 legs combined filing $27.2M
  2. BUYORBIMED ADVISORS LLC bought Sep 28, 2026 950,000 shares 3 legs combined filing $16.1M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. LAV Biosciences Fund V, L.P. filed Oct 16, 2026 Schedule 13G passive filing 11.1%
  2. SR One Capital Management, LLC filed Oct 5, 2026 Schedule 13D may seek influence 9,936,661 shares filing 9.3%
  3. ORBIMED ADVISORS LLC filed Oct 2, 2026 Schedule 13D may seek influence 14,913,764 shares filing 14%
  4. BCLS Fund III Investments, LP filed Oct 1, 2026 Schedule 13G passive filing 6.3%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Unregistered sales of equity securities; Amendments to articles or bylaws; change in fiscal year; Other events filing Sep 28, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.